Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Nantex Industry Co., Ltd. (2108.TW)
Kaohsiung, TW
Nantex Industry Co., Ltd., a global enterprise operating with its subsidiaries, specializes in the production, processing, and distribution of a diverse range of latex, rubber, and associated materials. Their product portfolio includes NANTEX synthetic rubber latex, widely utilized in the manufacturing of various gloves (such as examination, medical, household, and industrial types). It also finds applications in art papers, coated whiteboards, carpet backing, shoe insoles, non-woven fabric saturation (including those for artificial leathers), adhesives, plastic modifiers, and construction materials. Additionally, Nantex supplies NANCAR acrylonitrile-butadiene rubber, which is integral to the production of industrial and automotive components, including O-rings, gaskets, fuel hoses, shoe soles, various car parts, insulation systems, sporting equipment, rollers, and electronic components. Furthermore, they market DYNAPRENE thermoplastic elastomers, essential for automotive parts, building materials, components across the food and 3C sectors, sports merchandise, industrial goods, medical devices, and as agents for plastic modification. Another offering is NANCAR carbon masterbatch compounds, specifically designed for applications like O-rings, gaskets, fuel hoses, shoe soles, and other automotive components. Tracing its origins, the company was established in 1979 under the name President Fine Chemical Industry Co. Ltd., before adopting its current identity as NANTEX Industry Co., Ltd. in October 1991. Its headquarters are located in Kaohsiung, Taiwan.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.18% | +0.73% | +3.55% | +4.92% | +18.63% | +18.12% | +2.21% | -28.70% | -80.49% | +25.51% | +691.43% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%-16.0% Q1'26: +14.3% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%-27.2% Q1'26: +9.7% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+10.5% ★ Q1'26: -1.5% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+7.4% Q1'26: +12.4% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+9.1% ★ Q1'26: +16.4% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%-12.4% ★ Q1'26: +0.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×0.23× ★ Q1'26: 0.18× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
Dec 2029 1 Rev. Ana. 1 EPS Ana. |
Dec 2030 1 Rev. Ana. 1 EPS Ana. |
Dec 2031 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
13.81B
est: 13.36B (+3.4%)
|
12.39B
est: 12.49B (-0.8%)
|
14.40B
est: 13.35B (+7.9%)
|
23.52B
est: 20.18B (+16.5%)
|
11.67B
est: 13.26B (-12.0%)
|
8.94B
est: 11.99B (-25.4%)
|
11.36B
est: 11.99B (-5.2%)
|
13.36B
13.36B – 13.36B
+11.4% YoY
|
12.49B
12.49B – 12.49B
-6.5% YoY
|
13.35B
13.35B – 13.35B
+6.9% YoY
|
20.18B
20.18B – 20.18B
+51.2% YoY
|
13.26B
13.26B – 13.26B
-34.3% YoY
|
11.99B
11.99B – 11.99B
-9.6% YoY
|
| EBITDA |
2.42B
est: 3.57B (-32.2%)
|
2.34B
est: 3.33B (-29.7%)
|
5.01B
est: 3.56B (+40.7%)
|
10.11B
est: 5.39B (+87.7%)
|
2.62B
est: 3.54B (-26.1%)
|
1.61B
est: 3.20B (-49.6%)
|
1.73B
est: 2.63B (-34.3%)
|
2.93B
2.93B – 2.93B
+11.4% YoY
|
2.74B
2.74B – 2.74B
-6.5% YoY
|
2.93B
2.93B – 2.93B
+6.9% YoY
|
4.43B
4.43B – 4.43B
+51.2% YoY
|
2.91B
2.91B – 2.91B
-34.3% YoY
|
2.63B
2.63B – 2.63B
-9.6% YoY
|
| EBIT |
2.13B
est: 3.21B (-33.6%)
|
2.03B
est: 3.00B (-32.2%)
|
4.71B
est: 3.21B (+46.9%)
|
9.80B
est: 4.85B (+102.1%)
|
2.24B
est: 3.19B (-29.6%)
|
1.27B
est: 2.88B (-55.8%)
|
1.40B
est: 2.27B (-38.6%)
|
2.53B
2.53B – 2.53B
+11.4% YoY
|
2.37B
2.37B – 2.37B
-6.5% YoY
|
2.53B
2.53B – 2.53B
+6.9% YoY
|
3.83B
3.83B – 3.83B
+51.2% YoY
|
2.51B
2.51B – 2.51B
-34.3% YoY
|
2.27B
2.27B – 2.27B
-9.6% YoY
|
| Net Income |
1.53B
est: 1.73B (-11.4%)
|
1.43B
est: 1.74B (-18.2%)
|
3.55B
est: 3.35B (+6.0%)
|
7.35B
est: 8.27B (-11.2%)
|
1.19B
est: 1.80B (-33.7%)
|
714.04M
est: 1.32B (-45.7%)
|
562.47M
est: 1.15B (-51.2%)
|
1.52B
1.52B – 1.52B
+31.6% YoY
|
1.53B
1.53B – 1.53B
+0.6% YoY
|
2.93B
2.93B – 2.93B
+91.9% YoY
|
7.25B
7.25B – 7.25B
+147.2% YoY
|
1.58B
1.58B – 1.58B
-78.2% YoY
|
1.15B
1.15B – 1.15B
-26.9% YoY
|
| SGA |
1.22B
est: 1.55B (-21.2%)
|
1.15B
est: 1.45B (-20.8%)
|
1.54B
est: 1.55B (-0.7%)
|
2.22B
est: 2.35B (-5.6%)
|
1.51B
est: 1.54B (-2.4%)
|
1.17B
est: 1.40B (-16.1%)
|
1.37B
est: 1.44B (-5.2%)
|
1.61B
1.61B – 1.61B
+11.4% YoY
|
1.50B
1.50B – 1.50B
-6.5% YoY
|
1.61B
1.61B – 1.61B
+6.9% YoY
|
2.43B
2.43B – 2.43B
+51.2% YoY
|
1.60B
1.60B – 1.60B
-34.3% YoY
|
1.44B
1.44B – 1.44B
-9.6% YoY
|
| EPS |
3.12
est: 3.08 (+1.3%)
|
2.90
est: 3.10 (-6.5%)
|
7.21
est: 5.95 (+21.2%)
|
14.92
est: 14.71 (+1.4%)
|
2.42
est: 3.20 (-24.4%)
|
1.45
est: 2.34 (-38.0%)
|
1.14
est: 2.34 (-51.3%)
|
3.08
3.08 – 3.08
+31.6% YoY
|
3.10
3.10 – 3.10
+0.6% YoY
|
5.95
5.95 – 5.95
+91.9% YoY
|
14.71
14.71 – 14.71
+147.2% YoY
|
3.20
3.20 – 3.20
-78.2% YoY
|
2.34
2.34 – 2.34
-26.9% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 2/5 | 4/5 |
| 2026-05-11 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 2/5 | 4/5 |
| 2026-05-08 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 2/5 | 4/5 |
| 2026-05-07 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 2/5 | 4/5 |
| 2026-05-06 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 2/5 | 4/5 |
| 2026-05-05 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 2/5 | 4/5 |
| 2026-05-04 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 2/5 | 4/5 |
| 2026-04-30 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-29 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-28 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-27 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-24 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-23 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-22 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-21 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-20 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-17 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-16 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | State Street SPDR S&P Emerging Markets Small Cap ETF EWX | 0.03% | 185.2K | 0.65% |
| 2 | Avantis Emerging Markets Small Cap Equity ETF AVEE | 0.02% | 23.5K | 0.42% |
| 3 | Avantis Emerging Markets Equity UCITS ETF USD Acc AVEM.L | 0.01% | 20.1K | 0.35% |
| 4 | Vanguard FTSE All-World ex-US Small-Cap ETF VSS | 0.01% | 855.8K | 0.06% |
| 5 | Vanguard FTSE Emerging Markets Shares ETF VGE.AX | 0.00% | 26.5K | 0.48% |
| 6 | Vanguard FTSE Emerging Markets All Cap Index ETF VEE.TO | 0.00% | 59.8K | 0.26% |
| 7 | Vanguard FTSE Emerging Markets ETF VWO | 0.00% | 2.95M | 0.06% |
| 8 | Avantis Emerging Markets ex-China Equity ETF AVXC | 0.00% | 5.4K | 0.33% |
| 9 | Avantis Emerging Markets Equity ETF AVEM | 0.00% | 195.8K | 0.33% |
| 10 | Vanguard ESG International Stock ETF VSGX | 0.00% | 37.3K | 0.10% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Chien-Chu Hsu | President & Director | — | male |
| Hsiu Mei Chao | Financial Officer & Acting Manager | — | — |
| Jung-Yi Yeh | Manager of Administration Dept & Chief Corporate Governance Officer | — | — |
| Po-Ming Hou | Chief Executive Officer & Director | — | male |
| Sheng-Chung Huang | Assistant Vice President & Accounting Manager | — | male |
| Tung-Yuan Yang | Chairman & Chief Strategy Officer | — | male |
| Wen-Hsin Huang | Vice President | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 2108.TW
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
